The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients
NCT ID: NCT01704248
Last Updated: 2012-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2012-10-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
And what factors are associated with the failure of self-instillation eye drops with the Eye Drop Guide?
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After VDO recordings the participants will be switched to receive the other technique with the same instruction as the other group. Allow the same period of practice in the hospital and at home. The investigators again will make a 1-week telephone visit and 2-week follow up after self-practice at home. At week 4 the VDO recordings of self-instillation performance will be taken again under the same setting as previous records.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Routine self-instillation technique
The participants first use the Routine self-instillation technique for two weeks and then switch to the Eye Drop Guide technique for another two weeks.
Eye Drop Guide technique
1. Wash the hands.
2. Shake and then uncap the bottle.
3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand.
4. Use the lower lip of the cup to pull the lower lid down like what they normally do with the fingers.
5. Then place the upper lip down to cover the whole orbital rim area.
6. Tilt the head back if seated or standing.
7. Insert the bottle in the device all the way. Hold the bottle gently.
8. Look upward.
9. Squeeze the bottle one drop at a time until feel one drop instilled into the eye.
10. Close the eye 2-3 minutes.
For the non-seeing eye (best-corrected visual acuity ≤ 20/400) the participants should insert the bottle in the device before cover the eye then proceed with head tilt and look upward.
Eye Drop Guide technique
The participants first use the Eye Drop Guide technique for two weeks and then switch to the Routine self-instillation technique for another two weeks.
Routine self-instillation technique
1. Wash the hands.
2. Shake and then uncap the bottle.
3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand.
4. Lie down or tilt the head back if seated or standing.
5. Using the other hand, pull the lower lid down.
6. Hold the bottle over the eye and look up.
7. Squeeze the bottle one drop at a time until feel one drop instilled into the eye.
8. Close the eye 2-3 minutes.
For the participants using more than one medication after instilling one bottle the participants should wait 3-5 minutes between administering different medications in the same eye.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eye Drop Guide technique
1. Wash the hands.
2. Shake and then uncap the bottle.
3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand.
4. Use the lower lip of the cup to pull the lower lid down like what they normally do with the fingers.
5. Then place the upper lip down to cover the whole orbital rim area.
6. Tilt the head back if seated or standing.
7. Insert the bottle in the device all the way. Hold the bottle gently.
8. Look upward.
9. Squeeze the bottle one drop at a time until feel one drop instilled into the eye.
10. Close the eye 2-3 minutes.
For the non-seeing eye (best-corrected visual acuity ≤ 20/400) the participants should insert the bottle in the device before cover the eye then proceed with head tilt and look upward.
Routine self-instillation technique
1. Wash the hands.
2. Shake and then uncap the bottle.
3. Hold the bottle between the thumb, index, and/or middle finger of the dominant hand.
4. Lie down or tilt the head back if seated or standing.
5. Using the other hand, pull the lower lid down.
6. Hold the bottle over the eye and look up.
7. Squeeze the bottle one drop at a time until feel one drop instilled into the eye.
8. Close the eye 2-3 minutes.
For the participants using more than one medication after instilling one bottle the participants should wait 3-5 minutes between administering different medications in the same eye.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age of 18 years or over
* Self-administer eye drops regularly
Exclusion Criteria
* Patients who were blind from other diseases
* Patients with ophthalmic conditions that affect the eye drop instillation e.g. nystagmus, ptosis, exophthalmos, enophthalmos, microphthalmos, symblepharon, restrictive ophthalmoplegia
* Patients whose underlying conditions would affect the patient's adherence to the protocol e.g. dementia, psychosis, mental retardation, neurological conditions resulting in tremor or paralysis, rheumatoid arthritis, hand deformities
* Patients who are allergic to artificial tears eye drop
* Patients who are not able to return for the follow-up schedule
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Darin Sakiyalak, MD
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Siriraj Hospital, Mahidol University
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Darin Sakiyalak, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
440/2555 (EC4)
Identifier Type: -
Identifier Source: org_study_id